FEATURE
For someone diagnosed with pancreatic cancer, it can feel
like there is not a lot of hope. The statistics suggest that this person may only have a 6 percent chance of being alive in five years.
By comparison, the five-year survival rate for someone diagnosed
with breast cancer is 90 percent.
Baylor is embarking on a bold new path to improve the survival
rate for people with pancreatic cancer by establishing the Pancreatic
Cancer Research and Treatment Center at Baylor University
Medical Center at Dallas. The center will bring translational
research together with highly skilled surgeons, medical oncologists, research scientists, genetic counselors and other members of
the health care team for personalized care.
“We looked at our team in the clinic and in the lab, and we realized we had the necessary components to wage a strategic battle
against pancreatic cancer,” said Alan M. Miller, M.D., Ph.D.,
chief of oncology at Baylor Health Care System.
The new center is co-directed by Scott Celinski,
M.D., a surgical oncologist on the medical staff at
Baylor Charles A. Sammons Cancer Center, and
Carlos Becerra, M.D., medical director of the Swim
Across America Innovative Clinical Trials Center.
Daniel Von Hoff, M.D. is serving as senior research
advisor and is also the physician-in-chief